Dextrose Injection Market Demand and Covied-19 Impact latest Research Report with Upcoming Trends and Key Companies: Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmac

The "Global Dextrose Injection Market: 2020" Industry Report is a professional and in-depth study on the current state of the Dextrose Injection Market by CMI. The Dextrose Injection market is supposed to demonstrate a considerable growth during the forecast period of 2020 - 2027. The company profiles of all the key players and brands that are dominating the market have been given in this report. Their moves like product launches, joint ventures, mergers and acquisitions and the respective effect on the sales, import, export, revenue and CAGR values have been studied completely in the report. The scope of this Dextrose Injection market report can be expanded from market scenarios to comparative pricing between major players. The emerging trends along with major drivers, challenges and opportunities in the market are also identified and analysed in this report.

Dextrose Injection help organizations to develop cogent, coherent plans of action to improve their performance.

To Gain More Insights into the Market with Detailed Table of Content and Figures, Click Here -https://www.coherentmarketinsights.com/ongoing-insight/dextrose-injection-market-1835

Dextrose is a simple sugar made from corn, and is highly similar to glucose, as the two possess identical chemical properties. Dextrose plays a vital role in providing energy to body cells. Dextrose Injection is a non-pyrogenic and sterile solution for caloric supply and fluid replenishment. The route of administration of the dextrose injection is intravenous, i.e. into the vein. Its dosage depends upon an individual's body weight, age, as well as clinical condition. Only 5% of dextrose, combined with water, is injected into the vein to replace the lost fluids and provide carbohydrates to the body. However, dextrose, in this amount, can also be used to treat hypoglycemia (low blood sugar), insulin shock, and dehydration (fluid loss). A dextrose solution, along with amino acids and fats, provides nutrition the body, which is commonly termed as total parental nutrition. Moreover, dextrose solution (50%) is generally administered to a person suffering from hyperkalemia - a condition in which potassium levels in the body increase significantly.

Global Dextrose Injection Market Overview

A significant growth driver for the global dextrose injection market is the robust pipeline of drugs currently undergoing clinical trials. For instance, in 2017, Tri Service General Hospital concluded its 5% dextrose injection Phase 1 clinical trials. In the same year, the Hospital was reported to have completed its 10% dextrose injection Phase 2 clinical trials. For the record, 10% dextrose injection is used to treat the Carpal tunnel syndrome.

Escalating number of novel product launches by key market players is expected to further drive the global market growth. For instance, in 2018, SteriMAx Inc., engaged in the production, development, marketing, and distribution of essential hospital and retail pharmacy products. It subsequently launched the new drug, Bupivacaine Hydrochloride, in 8.25% dextrose injection indicated for spinal anesthesia.

New drug approvals are foreseen to boost the global dextrose injection market growth during the forecast period. For instance, in 2017, Clindamycin in dextrose injection (D5W) made by Water Street Healthcare Partners, was approved by the U.S. FDA. Clindamycin in dextrose injection (D5W) is used to treat bacterial infections, such as Pneumonia, by inhibiting bacteria growth in the body.

Request a PDF Sample Copy of the Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1835

This report sample includes
--Brief Introduction to the research report.
--Table of Contents (Scope covered as a part of the study)
--Top players in the market
--Research framework (presentation)
--Research methodology adopted by Coherent Market Insights

Furthermore, rising prevalence of diseases, such as hypoglycemia, would increase the demand for dextrose injection, which in turn, would fuel market growth. According to a survey conducted by the Center for Disease Prevention and Control (CDC), over 1.5 million people in the U.S. were diagnosed with hypoglycemia in 2016. However, the side effects caused by dextrose injection, such as fever, infection and blood clot formation at the site of injection, are pivotal factors restraining the growth of the global dextrose injection market.

The key players profiled in this report include:
-Pfizer Inc.
-Amphastar Pharmaceuticals Inc.
-Shangai Haixin group Co. Ltd.
-Seqirus GmbH
-Baxter International Inc.
-Shandong Qidu Pharmaceutical
-Sanctus drugs and pharmaceuticals Pvt.
-Hospira Inc.
-B Braun Medical Ltd.
-Aurobindo Pharmaceuticals Ltd.
-SteriMAx Inc.

Regions included:

o North America (United States, Canada, and Mexico)
o Europe (Germany, France, UK, Russia, and Italy)
o Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
o South America (Brazil, Argentina, Colombia)
o Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Global Dextrose Injection Market Taxonomy
By Product type:
o 5% Dextrose Injection
o 10% Dextrose Injection
o 50% Dextrose Injection
o 70% dextrose Injection
o Others

By Applications:
o First-aid Treatment
o Sports
o Trophotherapy
o Others

By Distribution Channel:
o Hospitals/clinics
o Online pharmacies
o Retail pharmacies

Table of Contents

-- Report Overview: It includes the Dextrose Injection market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

-- Executive Summary: This section of the report gives information about Dextrose Injection market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

-- Profiles of International Players: Here, key players of the Dextrose Injection market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

-- Regional Study: All of the regions and countries analyzed in the Dextrose Injection market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Buy This Research Study Report @ https://www.coherentmarketinsights.com/insight/buy-now/1835

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
sales@coherentmarketinsights.com

U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737

This release was published on openPR.